Gestational diabetes is the most common health-related challenge during pregnancy. Today, it is diagnosed in every fifth expectant mother in Finland.
A new study suggests that reducing daily sedentary time can have a positive effect on the risk factors of lifestyle diseases already in three months.
Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used to treat diabetes, and with more research may become a novel therapy for diabetic patients, according to new research published in Mayo Clinic Proceedings.
A new nationwide study led by researchers from NYU Grossman School of Medicine published online today in JAMA Network Open suggests that living in neighborhoods with higher availability of fast-food outlets across all regions of the United States is associated with higher subsequent risk of developing type 2 diabetes.
A team of researchers studying genetic data to identify hormone responses in a population of Mexican Americans with prediabetes, Type 2 diabetes, and obesity recently received a $3.5 million grant to fund a five-year study set to begin in late 2021.
University of California San Diego researchers, with international colleagues, describe how energy expenditure and heat production are regulated in obesity through a previously unknown cellular pathway.
Technion researchers are working on a novel treatment approach for treating type 2 diabetes using an autograft of muscle cells engineered to take in sugar at increased rates. Mice treated in this manner displayed normal blood sugar levels for months after a single procedure.
In a study published in the September issue of the journal Communications Biology, UNLV neuroscientists show that chronic hyperglycemia impairs working memory performance and alters fundamental aspects of working memory networks.
UCLA-led research finds ozone exposure contributes to the development of Type 2 diabetes; team examining Californians’ health finds pattern holds true, particularly among those with higher levels of leisure-time outdoor physical activity
Indiana University has received a five-year, $5 million grant from Eli Lilly and Co. to expand the Diabetes Impact Project, which aims to improve health equity in three Indianapolis neighborhoods where residents are predominantly people of color.
People who get migraines are less likely to develop type 2 diabetes. Today, scientists report the latest findings about the relationship between insulin production and the peptides that cause migraine pain. They will present their results at ACS Fall 2021.
MINNEAPOLIS – People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer’s disease, when compared to both people with type 2 diabetes not taking the drugs and people without diabetes. The new study, published in the August 11, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups.
Frequent activity breaks from sitting may improve fasting blood sugar (glucose) levels and stabilize daily fluctuations, according to new research. The study, the first of its length to explore the effects of activity breaks in “free-living” conditions, is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism. It was chosen as an APSselect article for August.
For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.
Patients with obesity or type 2 diabetes are at a higher risk of developing NAFLD and NASH.
A 1% increase in this substance in the blood is associated with a change in mortality risk similar to that of quitting smoking.
What The Study Did: This study at an institution of higher education in Colorado evaluated the association between self-reported protective behaviors and how common SARS-CoV-2 infection was among essential in-person employees during the first six months of the COVID-19 pandemic…
Clinical trial was conducted in the real-world setting of a workplace health plan
What The Study Did: This study investigated the association between time spent cycling and the risk of death from cardiovascular disease or any other cause among people with diabetes. Authors: Mathias Ried-Larsen, Ph.D., of Rigshospitalet in Copenhagen, is the corresponding…
Changes in direct medical cost and medications for diabetes in Beijing, China, from 2016 to 2018: Electronic insurance data analysis
Primary Care Poised to Provide Clinical Guidance, Answers About COVID-19 Testing, Vaccine Administration Researchers examined the role of primary care physicians and other clinicians in delivering vaccinations in the United States. They used two main datasets to create an in-depth…
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death. This is shown by a…
Scientists at the University of Cambridge have identified rare genetic variants – carried by one in 3,000 people – that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect. Type 2…
Increased heart disease prevention education and awareness needed for younger, at-risk patients
Diabetics exert less force to hold an object than people with other diseases that affect the nervous system. Grip force is a key behavioral biomarker to detect incipient diabetic neuropathy
What The Study Did: R ates at which patients with type 2 diabetes received diabetes-related health services prior to and during the COVID-19 pandemic are compared in this study. Authors: Ateev Mehrotra, M.D., M.P.H., of Harvard Medical School in Boston,…
University of Liverpool teams up with BARD1 Life Sciences Ltd for type 3C diabetes test
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
Not one’s current high blood pressure, but the cumulative effect of having had hypertension for years is what significantly increases the risk of cardiovascular disease
Managing type 2 diabetes typically involves losing weight, exercise and medication, but new research by Dr. Makoto Fukuda and colleagues at Baylor College of Medicine and other institutions suggests that there may be other ways to control the condition through…
A recently published review explores the role of epigenetic factors in the development and progression of type 1 diabetes
New research published this week challenges a popular belief that intermittent fasting diets such as alternate day fasting or the ‘5:2’ are the most effective ways to lose weight. Over recent years, diets which see people fast on a few…
A new computational framework incorporates social interactions to analyze how best to communicate about new medical guidelines to encourage their adoption
Women exposed to higher levels of air pollution during pregnancy have babies who grow unusually fast in the first months after birth, putting on excess fat that puts them at risk of obesity and related diseases later in life, new…
Paper urges identifying epidemiological features of CVD in Asian countries to combat epidemic
It all started, when Patrice Cani, FNRS researcher at University of Louvain (UCLouvain), and his team repeatedly observed that a bacterium (called Subdoligranulum) is almost absent in obese and diabetic people, while it is systematically present in healthy people. So,…
The alterations link obesity to a brain condition similar to obsessive-compulsive disorder, which affects the same areas of the brain
Percentage of adults with diabetes achieving glycemic control declined between 2007-2010 and 2015-2018
Researchers at Staffordshire University have developed a new low-cost method to help prevent life-threatening foot ulcers in diabetic patients
Those with diabetes, frequent sleep problems were 87% more likely to die in following 9 years
In a paper published by the Journal of Sleep Research , researchers reveal how they examined data* from half a million middle-aged UK participants asked if they had trouble falling asleep at night or woke up in the middle of…
Many modern fitness trackers and smartwatches feature integrated LEDs. The green light emitted, whether continuous or pulsed, penetrates the skin and can be used to measure the wearer’s heart rate during physical activity or while at rest. These watches have…
An international research team, including the University of South Florida Health Informatics Institute, created and validated a predictive model with potential for early monitoring of infants at risk for type 1 diabetes
Salk research shows how to optimize the production of insulin-producing cells from stem cells
DALLAS – June 4, 2021 – Increasing a protein concentrated in brown fat appears to lower blood sugar, promote insulin sensitivity, and protect against fatty liver disease by remodeling white fat to a healthier state, a new study led by UT Southwestern scientists suggests. The finding, published online in Nature Communications, could eventually lead to new solutions for patients with diabetes and related conditions.
Durham, NC — Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today…
A new study finds people who consume two servings of fruit per day have 36 percent lower odds of developing type 2 diabetes than those who consume less than half a serving. The research was published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
What The Study Did: Researchers investigated the effect of real-time continuous glucose monitoring on glycemic control among patients with insulin-treated diabetes. Authors: Andrew J. Karter, Ph.D., of Kaiser Permanente in Oakland, California, is the corresponding author. To access the embargoed…
Kaiser Permanente study finds monitors improve blood sugar control in selected insulin-treated patients.